NCT00458835View on ClinicalTrials.gov

Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422)

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Allergic Rhinitis
Interventions
DRUG

Ciclesonide

Trial Locations (1)

Unknown

ALTANA Pharma, Austin

Sponsors
All Listed Sponsors
lead

Covis Pharma S.à.r.l.

INDUSTRY

NCT00458835 - Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422) | Biotech Hunter | Biotech Hunter